Invivyd, Inc. SEC filings IVVD
Invivyd, Inc. has 448 filings in SEC EDGAR's recent list, going back to Nov 12, 2020. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 29, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Sep 1, 2026 | Aug 30, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Listing notice
|
Jul 24, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Other events
|
Jul 6, 2026 | Jul 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 19, 2026 | May 19, 2026 |
| S-8 | Employee stock plan registration | May 14, 2026 | — |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Other events
|
Apr 9, 2026 | Apr 9, 2026 |
| ARS | Annual report to shareholders | Apr 6, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 6, 2026 | — |
| DEF 14A | Proxy statement | Apr 6, 2026 | May 19, 2026 |
| 10-K | Annual report | Mar 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 5, 2026 | Mar 5, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 8, 2026 | Jan 8, 2026 |
| EFFECT | Filing | Dec 23, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 23, 2025 | Dec 23, 2025 |
| CORRESP | Letter to the SEC | Dec 19, 2025 | — |
| S-3/A | Filing | Dec 19, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 24, 2025 | Nov 24, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 19, 2025 | Nov 17, 2025 |
| 424B5 | Prospectus supplement | Nov 19, 2025 | — |
| FWP | Free writing prospectus | Nov 17, 2025 | — |
| 424B5 | Prospectus supplement | Nov 17, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Other events
|
Oct 30, 2025 | Oct 30, 2025 |
| 8-K |
Current report
Other events
|
Oct 6, 2025 | Oct 6, 2025 |
| S-3 | Shelf registration | Oct 2, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Sep 24, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 22, 2025 | Aug 20, 2025 |
| 424B5 | Prospectus supplement | Aug 22, 2025 | — |
| FWP | Free writing prospectus | Aug 20, 2025 | — |
| 424B5 | Prospectus supplement | Aug 20, 2025 | — |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Other events
|
Jul 2, 2025 | Jul 2, 2025 |
| 8-K |
Current report
Other events
|
Jun 26, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 20, 2025 | May 20, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
May 15, 2025 | May 15, 2025 |
| 8-K |
Current report
Other events
|
May 12, 2025 | May 12, 2025 |
| 8-K |
Current report
Listing notice
|
Apr 25, 2025 | Apr 21, 2025 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Apr 21, 2025 | Apr 18, 2025 |
| ARS | Annual report to shareholders | Apr 7, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 7, 2025 | — |
| DEF 14A | Proxy statement | Apr 7, 2025 | May 20, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 26, 2025 | Mar 22, 2025 |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2025 | Mar 20, 2025 |
| 8-K |
Current report
Other events
|
Mar 5, 2025 | Mar 5, 2025 |
| 8-K |
Current report
Other events
|
Feb 24, 2025 | Feb 21, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 3, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Other events
|
Jan 27, 2025 | Jan 27, 2025 |
| 8-K |
Current report
Other events
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Listing notice
|
Dec 27, 2024 | Dec 27, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 2, 2024 | Nov 27, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Oct 29, 2024 | Oct 29, 2024 |
| 8-K |
Current report
Other events
|
Sep 23, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Other events
|
Sep 6, 2024 | Sep 6, 2024 |
| 8-K |
Current report
Other events
|
Sep 4, 2024 | Sep 4, 2024 |
| 8-K |
Current report
Other events
|
Sep 3, 2024 | Sep 3, 2024 |
| 8-K |
Current report
Other events
|
Aug 27, 2024 | Aug 27, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Other events
|
Jun 14, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
May 31, 2024 | May 30, 2024 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
May 22, 2024 | May 21, 2024 |
| S-8 | Employee stock plan registration | May 9, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Other events
|
May 7, 2024 | May 7, 2024 |
| EFFECT | Filing | Apr 19, 2024 | — |
| ARS | Annual report to shareholders | Apr 18, 2024 | Dec 31, 2023 |
| CORRESP | Letter to the SEC | Apr 18, 2024 | — |
| DEF 14A | Proxy statement | Apr 18, 2024 | May 21, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 12, 2024 | Apr 11, 2024 |
| 8-K |
Current report
Other events
|
Apr 4, 2024 | Apr 4, 2024 |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 25, 2024 | Mar 22, 2024 |
| UPLOAD | Letter from the SEC | Feb 23, 2024 | — |
| S-3 | Shelf registration | Feb 9, 2024 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 9, 2024 | Feb 5, 2024 |
| 8-K |
Current report
Other events
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Other events
|
Jan 3, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Material agreement
|
Dec 22, 2023 | Dec 22, 2023 |
| 424B5 | Prospectus supplement | Dec 22, 2023 | — |
| 8-K |
Current report
Other events
|
Dec 18, 2023 | Dec 18, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Other events
|
Sep 11, 2023 | Sep 11, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 5, 2023 | Sep 5, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 27, 2023 | Jul 25, 2023 |
| 8-K |
Current report
Other events
|
Jun 29, 2023 | Jun 29, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 25, 2023 | May 23, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
May 2, 2023 | Apr 26, 2023 |
| ARS | Annual report to shareholders | Apr 10, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 10, 2023 | — |
| DEF 14A | Proxy statement | Apr 10, 2023 | May 23, 2023 |
| PRE 14A | Preliminary proxy statement | Mar 31, 2023 | May 23, 2023 |
| 10-K | Annual report | Mar 23, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Other events
|
Mar 6, 2023 | Mar 6, 2023 |
| 8-K |
Current report
Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Dec 6, 2022 | Dec 6, 2022 |
| D | Filing | Nov 29, 2022 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Nov 17, 2022 | Nov 15, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 24, 2022 | Oct 20, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 13, 2022 | Oct 11, 2022 |
| EFFECT | Filing | Oct 5, 2022 | — |
| CORRESP | Letter to the SEC | Oct 3, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 30, 2022 | — |
| S-3 | Shelf registration | Sep 28, 2022 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 13, 2022 | Sep 9, 2022 |
| 8-K |
Current report
Other events
|
Sep 12, 2022 | Sep 12, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 5, 2022 | Jul 1, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 30, 2022 | Jun 24, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2022 | Jun 22, 2022 |
| DEFA14C | Filing | Jun 21, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Jun 21, 2022 | Jun 17, 2022 |
| DFAN14A | Filing | Jun 6, 2022 | — |
| DEFC14C | Filing | Jun 2, 2022 | — |
| CORRESP | Letter to the SEC | May 31, 2022 | — |
| PRER14C | Filing | May 31, 2022 | — |
| UPLOAD | Letter from the SEC | May 27, 2022 | — |
| DEFA14C | Filing | May 19, 2022 | — |
| 8-K |
Current report
Other events
|
May 19, 2022 | May 19, 2022 |
| PREC14C | Filing | May 19, 2022 | — |
| S-8 | Employee stock plan registration | May 13, 2022 | — |
| 10-Q | Quarterly report | May 13, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 13, 2022 | May 13, 2022 |
| 10-K/A | Amended annual report | Apr 29, 2022 | Dec 31, 2021 |
| DEFC14A | Filing | Apr 29, 2022 | — |
| PRRN14A | Filing | Apr 27, 2022 | — |
| PREC14A | Filing | Apr 26, 2022 | — |
| PRRN14A | Filing | Apr 25, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 18, 2022 | — |
| PREC14A | Filing | Apr 11, 2022 | — |
| 10-K | Annual report | Mar 31, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2022 | Mar 30, 2022 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 21, 2022 | Mar 18, 2022 |
| 8-K/A |
Amended current report
Officer or director change
|
Mar 21, 2022 | Feb 23, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 1, 2022 | Feb 23, 2022 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 23, 2022 | Feb 23, 2022 |
| 8-K |
Current report
Other events
|
Feb 22, 2022 | Feb 18, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 18, 2022 | Feb 14, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 13, 2022 | Jan 12, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 14, 2021 | Dec 14, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 29, 2021 | Nov 29, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 22, 2021 | Nov 19, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 16, 2021 | Nov 16, 2021 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2021 | Nov 15, 2021 |
| 8-K |
Current report
Other events
|
Oct 19, 2021 | Oct 19, 2021 |
| 8-K |
Current report
Other events
|
Sep 29, 2021 | Sep 29, 2021 |
| 10-Q | Quarterly report | Sep 20, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Sep 20, 2021 | Sep 20, 2021 |
| 8-K |
Current report
Other events
|
Sep 10, 2021 | Sep 10, 2021 |
| S-8 | Employee stock plan registration | Aug 23, 2021 | — |
| SEC STAFF LETTER | Filing | Aug 13, 2021 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 10, 2021 | Aug 10, 2021 |
| 424B4 | Prospectus | Aug 6, 2021 | — |
| EFFECT | Filing | Aug 5, 2021 | — |
| S-1MEF | Filing | Aug 5, 2021 | — |
| CERT | Filing | Aug 5, 2021 | — |
| S-1/A | Amended registration statement | Aug 4, 2021 | — |
| CORRESP | Letter to the SEC | Aug 3, 2021 | — |
| CORRESP | Letter to the SEC | Aug 3, 2021 | — |
| CORRESP | Letter to the SEC | Aug 3, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 3, 2021 | — |
| 8-A12B | Filing | Aug 3, 2021 | — |
| CORRESP | Letter to the SEC | Aug 2, 2021 | — |
| S-1/A | Amended registration statement | Aug 2, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 26, 2021 | — |
| SEC STAFF LETTER | Filing | Jul 16, 2021 | — |
| CORRESP | Letter to the SEC | Jul 16, 2021 | — |
| S-1 | Registration statement | Jul 16, 2021 | — |
| DRS/A | Filing | Jul 13, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2021 | — |
| DRSLTR | Filing | Jun 28, 2021 | — |
| DRS/A | Filing | Jun 28, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 16, 2021 | — |
| DRS | Filing | May 21, 2021 | — |
| D | Filing | Apr 30, 2021 | — |
| D | Filing | Nov 12, 2020 | — |
| D | Filing | Nov 12, 2020 | — |
Showing 199 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IVVD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Haven, CT
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1832038
- Former names
- Adagio Therapeutics, Inc. (until Sep 12, 2022)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.